EpiPen maker's CEO set to defend prices amid public outcry

Congress EpiPen

Mylan faces new scrutiny over price hikes for its anti-allergy EpiPen



from CBC | Health News http://ift.tt/2cQpKwX

Aucun commentaire:

Enregistrer un commentaire